The in vivo study further verifies that metformin suppresses tumor growth (Fig 5B), accompanied by the down-regulation of cyclin D1 and the up-regulation of p21CIP1, p27KIP1, and p53. This evidence concerns the gene CDKN1A and neoplasm.